Literature DB >> 26729813

Antibody blockade of IL-17 family cytokines in immunity to acute murine oral mucosal candidiasis.

Natasha Whibley1, Elaine Tritto2, Elisabetta Traggiai2, Frank Kolbinger2, Pierre Moulin2, Dominique Brees2, Bianca M Coleman1, Anna J Mamo1, Abhishek V Garg1, Jillian R Jaycox1, Ulrich Siebenlist3, Michael Kammüller4, Sarah L Gaffen5.   

Abstract

Antibodies targeting IL-17A or its receptor, IL-17RA, are approved to treat psoriasis and are being evaluated for other autoimmune conditions. Conversely, IL-17 signaling is critical for immunity to opportunistic mucosal infections caused by the commensal fungus Candida albicans, as mice and humans lacking the IL-17R experience chronic mucosal candidiasis. IL-17A, IL-17F, and IL-17AF bind the IL-17RA-IL-17RC heterodimeric complex and deliver qualitatively similar signals through the adaptor Act1. Here, we used a mouse model of acute oropharyngeal candidiasis to assess the impact of blocking IL-17 family cytokines compared with specific IL-17 cytokine gene knockout mice. Anti-IL-17A antibodies, which neutralize IL-17A and IL-17AF, caused elevated oral fungal loads, whereas anti-IL-17AF and anti-IL-17F antibodies did not. Notably, there was a cooperative effect of blocking IL-17A, IL-17AF, and IL-17F together. Termination of anti-IL-17A treatment was associated with rapid C. albicans clearance. IL-17F-deficient mice were fully resistant to oropharyngeal candidiasis, consistent with antibody blockade. However, IL-17A-deficient mice had lower fungal burdens than anti-IL-17A-treated mice. Act1-deficient mice were much more susceptible to oropharyngeal candidiasis than anti-IL-17A antibody-treated mice, yet anti-IL-17A and anti-IL-17RA treatment caused equivalent susceptibilities. Based on microarray analyses of the oral mucosa during infection, only a limited number of genes were associated with oropharyngeal candidiasis susceptibility. In sum, we conclude that IL-17A is the main cytokine mediator of immunity in murine oropharyngeal candidiasis, but a cooperative relationship among IL-17A, IL-17AF, and IL-17F exists in vivo. Susceptibility displays the following hierarchy: IL-17RA- or Act1-deficiency > anti-IL-17A + anti-IL-17F antibodies > anti-IL-17A or anti-IL-17RA antibodies > IL-17A deficiency. © Society for Leukocyte Biology.

Entities:  

Keywords:  IL-17R; Th17; anticytokine therapy; fungal; psoriasis

Mesh:

Substances:

Year:  2016        PMID: 26729813      PMCID: PMC4952011          DOI: 10.1189/jlb.4A0915-428R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  74 in total

1.  Mouse model of oropharyngeal candidiasis.

Authors:  Norma V Solis; Scott G Filler
Journal:  Nat Protoc       Date:  2012-03-08       Impact factor: 13.491

2.  CCL28 has dual roles in mucosal immunity as a chemokine with broad-spectrum antimicrobial activity.

Authors:  Kunio Hieshima; Haruo Ohtani; Michiko Shibano; Dai Izawa; Takashi Nakayama; Yuri Kawasaki; Fumio Shiba; Mitsuru Shiota; Fuminori Katou; Takuya Saito; Osamu Yoshie
Journal:  J Immunol       Date:  2003-02-01       Impact factor: 5.422

3.  Orosomucoid 1 drives opportunistic infections through the polarization of monocytes to the M2b phenotype.

Authors:  Kiwamu Nakamura; Ichiaki Ito; Makiko Kobayashi; David N Herndon; Fujio Suzuki
Journal:  Cytokine       Date:  2015-02-14       Impact factor: 3.861

Review 4.  The cup runneth over: lessons from the ever-expanding pool of primary immunodeficiency diseases.

Authors:  Joshua D Milner; Steven M Holland
Journal:  Nat Rev Immunol       Date:  2013-07-26       Impact factor: 53.106

5.  Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis.

Authors:  Iliyan D Iliev; Vincent A Funari; Kent D Taylor; Quoclinh Nguyen; Christopher N Reyes; Samuel P Strom; Jordan Brown; Courtney A Becker; Phillip R Fleshner; Marla Dubinsky; Jerome I Rotter; Hanlin L Wang; Dermot P B McGovern; Gordon D Brown; David M Underhill
Journal:  Science       Date:  2012-06-06       Impact factor: 47.728

6.  Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells.

Authors:  Eva V Acosta-Rodriguez; Laura Rivino; Jens Geginat; David Jarrossay; Marco Gattorno; Antonio Lanzavecchia; Federica Sallusto; Giorgio Napolitani
Journal:  Nat Immunol       Date:  2007-05-07       Impact factor: 25.606

7.  Genetic origins of hyper-IgE syndrome.

Authors:  Yoshiyuki Minegishi; Hajime Karasuyama
Journal:  Curr Allergy Asthma Rep       Date:  2008-09       Impact factor: 4.806

8.  STAT3 single-nucleotide polymorphisms and STAT3 mutations associated with hyper-IgE syndrome are not responsible for increased serum IgE serum levels in asthma families.

Authors:  Matthias Wjst; Peter Lichtner; Thomas Meitinger; Bodo Grimbacher
Journal:  Eur J Hum Genet       Date:  2008-10-08       Impact factor: 4.246

9.  Evidence that a neutrophil-keratinocyte crosstalk is an early target of IL-17A inhibition in psoriasis.

Authors:  Kristian Reich; Kim A Papp; Robert T Matheson; John H Tu; Robert Bissonnette; Marc Bourcier; David Gratton; Rodion A Kunynetz; Yves Poulin; Les A Rosoph; Georg Stingl; Wolfgang M Bauer; Janeen M Salter; Thomas M Falk; Norbert A Blödorn-Schlicht; Wolfgang Hueber; Ulrike Sommer; Martin M Schumacher; Thomas Peters; Ernst Kriehuber; David M Lee; Grazyna A Wieczorek; Frank Kolbinger; Conrad C Bleul
Journal:  Exp Dermatol       Date:  2015-05-08       Impact factor: 3.960

10.  Neutrophils Do Not Express IL-17A in the Context of Acute Oropharyngeal Candidiasis.

Authors:  Anna R Huppler; Akash H Verma; Heather R Conti; Sarah L Gaffen
Journal:  Pathogens       Date:  2015-07-24
View more
  23 in total

1.  IL-17 Receptor Signaling in Oral Epithelial Cells Is Critical for Protection against Oropharyngeal Candidiasis.

Authors:  Heather R Conti; Vincent M Bruno; Erin E Childs; Sean Daugherty; Joseph P Hunter; Bemnet G Mengesha; Danielle L Saevig; Matthew R Hendricks; Bianca M Coleman; Lucas Brane; Norma Solis; J Agustin Cruz; Akash H Verma; Abhishek V Garg; Amy G Hise; Jonathan P Richardson; Julian R Naglik; Scott G Filler; Jay K Kolls; Satrajit Sinha; Sarah L Gaffen
Journal:  Cell Host Microbe       Date:  2016-10-27       Impact factor: 21.023

Review 2.  Interleukin 17 Family Cytokines: Signaling Mechanisms, Biological Activities, and Therapeutic Implications.

Authors:  Leticia Monin; Sarah L Gaffen
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-04-02       Impact factor: 10.005

3.  Oral epithelial IL-22/STAT3 signaling licenses IL-17-mediated immunity to oral mucosal candidiasis.

Authors:  Felix E Y Aggor; Timothy J Break; Giraldina Trevejo-Nuñez; Natasha Whibley; Bianca M Coleman; Rachel D Bailey; Daniel H Kaplan; Julian R Naglik; Wei Shan; Amol C Shetty; Carrie McCracken; Scott K Durum; Partha S Biswas; Vincent M Bruno; Jay K Kolls; Michail S Lionakis; Sarah L Gaffen
Journal:  Sci Immunol       Date:  2020-06-05

4.  The Interleukin (IL) 17R/IL-22R Signaling Axis Is Dispensable for Vulvovaginal Candidiasis Regardless of Estrogen Status.

Authors:  Brian M Peters; Bianca M Coleman; Hubertine M E Willems; Katherine S Barker; Felix E Y Aggor; Ellyse Cipolla; Akash H Verma; Srinivas Bishu; Anna H Huppler; Vincent M Bruno; Sarah L Gaffen
Journal:  J Infect Dis       Date:  2020-04-07       Impact factor: 5.226

5.  An IL-17F.S65L Knock-In Mouse Reveals Similarities and Differences in IL-17F Function in Oral Candidiasis: A New Tool to Understand IL-17F.

Authors:  Chunsheng Zhou; Leticia Monin; Rachael Gordon; Felix E Y Aggor; Rami Bechara; Tara N Edwards; Daniel H Kaplan; Sebastien Gingras; Sarah L Gaffen
Journal:  J Immunol       Date:  2020-06-29       Impact factor: 5.422

Review 6.  Candida albicans-epithelial interactions and induction of mucosal innate immunity.

Authors:  Julian R Naglik; Annika König; Bernhard Hube; Sarah L Gaffen
Journal:  Curr Opin Microbiol       Date:  2017-11-17       Impact factor: 7.934

7.  IL-22 neutralizing autoantibodies impair fungal clearance in murine oropharyngeal candidiasis model.

Authors:  Rudolf Bichele; Jaanika Kärner; Kai Truusalu; Imbi Smidt; Reet Mändar; Heather R Conti; Sarah L Gaffen; Pärt Peterson; Martti Laan; Kai Kisand
Journal:  Eur J Immunol       Date:  2017-12-11       Impact factor: 5.532

Review 8.  Regulation of host-microbe interactions at oral mucosal barriers by type 17 immunity.

Authors:  Sarah L Gaffen; Niki M Moutsopoulos
Journal:  Sci Immunol       Date:  2020-01-03

9.  The intraspecies diversity of C. albicans triggers qualitatively and temporally distinct host responses that determine the balance between commensalism and pathogenicity.

Authors:  F A Schönherr; F Sparber; F R Kirchner; E Guiducci; K Trautwein-Weidner; A Gladiator; N Sertour; U Hetzel; G T T Le; N Pavelka; C d'Enfert; M-E Bougnoux; C F Corti; S LeibundGut-Landmann
Journal:  Mucosal Immunol       Date:  2017-02-08       Impact factor: 7.313

10.  Oral epithelial cells orchestrate innate type 17 responses to Candida albicans through the virulence factor candidalysin.

Authors:  Akash H Verma; Jonathan P Richardson; Chunsheng Zhou; Bianca M Coleman; David L Moyes; Jemima Ho; Anna R Huppler; Kritika Ramani; Mandy J McGeachy; Ilgiz A Mufazalov; Ari Waisman; Lawrence P Kane; Partha S Biswas; Bernhard Hube; Julian R Naglik; Sarah L Gaffen
Journal:  Sci Immunol       Date:  2017-11-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.